2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 34326166 | Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies. | 2021 Jul | 1 |
| 2 | 26517678 | Inhibition of Lyn is a promising treatment for mantle cell lymphoma with bortezomib resistance. | 2015 Nov 10 | 1 |